PL
(¥thousand) | FY2/13 | FY2/14 | ||||||||||||
Q1 | Q2 | 1H | Q3 | Q4 | 2H | Full-Year | Q1 | Q2 | 1H | Q3 | Q4 | 2H | Full-Year | |
Net sales Cost of sales Gross profit Selling, general and administrative expenses Operating income Non-operating income Foreign exchange gains Non-operating expenses Ordinary income Extraordinary income Extraordinary losses Income (loss) before income taxes and minority interests Total income taxes Profit (loss) attributable to non-controlling interests Profit (loss) attributable to owners of parent EBITDA EBITDA=Operating income+Technical support fee+Interest expenses+Depreciation | 4,728,509 3,350,143 1,378,365 884,268 494,096 79,834 - 3,386 570,545 77 996 569,625 227,935 9,124 332,565 552,385 | 3,950,865 2,654,731 1,296,133 896,479 399,653 24,457 - 550 423,560 4,611 301,398 126,773 111,426 (22,140) 37,487 461,675 | 8,679,375 6,004,875 2,674,499 1,780,748 893,750 104,292 - 3,937 994,105 4,688 302,395 696,399 339,362 (13,015) 370,052 1,014,060 | 3,886,900 2,674,687 1,212,213 864,528 347,684 15,816 4,228 729 362,772 - (1,604) 364,377 170,962 (1,974) 195,389 409,966 | 3,830,664 2,634,235 1,196,428 967,708 228,720 31,583 23,312 (1,108) 261,412 17,084 1,507 276,989 74,111 2,963 199,914 293,372 | 7,717,564 5,308,922 2,408,641 1,832,236 576,405 47,400 27,541 (379) 624,184 17,084 (97) 641,366 245,073 989 395,303 703,338 | 16,396,939 11,313,798 5,083,141 3,612,985 1,470,155 151,692 27,541 3,558 1,618,290 21,773 302,297 1,337,765 584,435 (12,026) 765,356 1,717,398 | 4,656,831 3,107,223 1,549,608 987,123 562,485 22,394 13,999 3,259 581,619 1,756 43 583,332 272,948 1,337 309,047 634,788 | 4,224,845 2,963,231 1,261,614 980,217 281,396 11,259 (6,982) 974 291,681 2,367 404 293,644 128,793 3,030 161,820 360,799 | 8,881,677 6,070,454 2,811,222 1,967,341 843,881 33,653 7,017 4,234 873,301 4,124 448 876,976 401,741 4,368 470,867 995,587 | 3,545,402 2,468,833 1,076,569 920,131 156,437 18,419 9,555 1,867 172,988 524 22,538 150,975 78,904 3,654 68,417 235,865 | 5,189,203 3,838,309 1,350,894 1,064,667 286,227 8,774 (3,892) (637) 295,638 17 163 295,492 39,762 7,172 248,557 378,816 | 8,734,606 6,307,142 2,427,464 1,984,799 442,664 27,193 5,662 1,230 468,627 541 22,701 446,468 118,666 10,826 316,974 614,681 | 17,616,284 12,377,597 5,238,686 3,952,140 1,286,546 60,847 12,679 5,464 1,341,929 4,665 23,149 1,323,445 520,408 15,194 787,841 1,610,268 |
Foreign exchange rate (Average exchange rate of cumulative period) /US$ | 79.36 | 79.77 | 79.77 | 79.39 | 79.80 | 79.80 | 79.80 | 92.46 | 95.73 | 95.73 | 96.83 | 97.73 | 97.73 | 97.73 |
Capital investment (including acquisition of leased assets) Depreciation R&D expenses | 16,785 54,407 97,595 | 58,281 57,349 106,411 | 75,066 111,757 204,006 | 75,901 58,617 110,818 | 71,313 62,310 120,329 | 147,214 120,928 231,147 | 222,281 232,685 435,154 | 274,679 69,411 103,829 | 9,333 72,527 123,167 | 284,012 141,938 226,997 | 108,855 74,276 120,644 | 84,571 87,578 116,455 | 193,427 161,855 237,099 | 477,440 303,794 464,097 |
Composition ratio (%) COGS ratio Gross profit margin SG&A expenses ratio Operating income margin Ordinary income margin Net income margin R&D expenses ratio | 70.8% 29.2% 18.7% 10.4% 12.1% 7.0% 2.1% | 67.2% 32.8% 22.7% 10.1% 10.7% 0.9% 2.7% | 69.2% 30.8% 20.5% 10.3% 11.5% 4.3% 2.4% | 68.8% 31.2% 22.2% 8.9% 9.3% 5.0% 2.9% | 68.8% 31.2% 25.3% 6.0% 6.8% 5.2% 3.1% | 68.8% 31.2% 23.7% 7.5% 8.1% 5.1% 3.0% | 69.0% 31.0% 22.0% 9.0% 9.9% 4.7% 2.7% | 66.7% 33.3% 21.2% 12.1% 12.5% 6.6% 2.2% | 70.1% 29.9% 23.2% 6.7% 6.9% 3.8% 2.9% | 68.3% 31.7% 22.2% 9.5% 9.8% 5.3% 2.6% | 69.6% 30.4% 26.0% 4.4% 4.9% 1.9% 3.4% | 74.0% 26.0% 20.5% 5.5% 5.7% 4.8% 2.2% | 72.2% 27.8% 22.7% 5.1% 5.4% 3.6% 2.7% | 70.3% 29.7% 22.4% 7.3% 7.6% 4.5% 2.6% |
Year-over-year basis (%) Net sales Cost of sales Gross profit Selling, general and administrative expenses Operating income | 45.2% 47.7% 39.5% 3.5% 270.0% | 5.5% 3.7% 9.3% 0.8% 34.8% | 24.0% 24.4% 23.0% 2.1% 107.8% | 2.0% 5.0% -4.2% -1.4% -10.4% | -13.4% -18.9% 2.0% 4.5% -7.5% | -6.3% -8.4% -1.2% 1.6% -9.2% | 7.6% 6.5% 10.2% 1.9% 38.0% | -1.5% -7.3% 12.4% 11.6% 13.8% | 6.9% 11.6% -2.7% 9.3% -29.6% | 2.3% 1.1% 5.1% 10.5% -5.6% | -8.8% -7.7% -11.2% 6.4% -55.0% | 35.5% 45.7% 12.9% 10.0% 25.1% | 13.2% 18.8% 0.8% 8.3% -23.2% | 7.4% 9.4% 3.1% 9.4% -12.5% |
By business segment
(¥thousand) | FY2/13 | FY2/14 | ||||||||||||
Q1 | Q2 | 1H | Q3 | Q4 | 2H | Full-Year | Q1 | Q2 | 1H | Q3 | Q4 | 2H | Full-Year | |
Net sales Machinery Business Segment Pharmaceutical Products Industrial Products Chemicals Business Segment Pharmaceutical Excipients Food Preservatives Dietary Supplement Products | 4,728,509 | 3,950,865 | 8,679,375 | 3,886,900 | 3,830,664 | 7,717,564 | 16,396,939 | 4,656,831 | 4,224,845 | 8,881,677 | 3,545,402 | 5,189,203 | 8,734,606 | 17,616,284 |
3,240,641 | 2,376,530 | 5,617,172 | 2,078,342 | 2,219,310 | 4,297,652 | 9,914,824 | 3,048,680 | 2,684,594 | 5,733,274 | 1,933,878 | 3,337,480 | 5,271,358 | 11,004,633 | |
2,714,112 | 1,959,180 | 4,673,292 | 1,800,466 | 1,774,468 | 3,574,935 | 8,248,227 | 2,801,399 | 2,219,521 | 5,020,921 | 1,756,188 | 2,960,484 | 4,716,673 | 9,737,594 | |
526,528 | 417,350 | 943,879 | 277,875 | 444,841 | 722,717 | 1,666,596 | 247,280 | 465,072 | 712,353 | 177,689 | 376,995 | 554,685 | 1,267,038 | |
1,487,868 | 1,574,334 | 3,062,203 | 1,808,558 | 1,611,354 | 3,419,912 | 6,482,115 | 1,608,151 | 1,540,251 | 3,148,402 | 1,611,524 | 1,851,723 | 3,463,247 | 6,611,650 | |
450,933 | 547,157 | 998,090 | 572,679 | 470,174 | 1,042,854 | 2,040,945 | 508,181 | 470,078 | 978,260 | 448,385 | 546,124 | 994,509 | 1,972,769 | |
487,953 | 435,085 | 923,039 | 501,043 | 465,086 | 966,129 | 1,889,169 | 473,884 | 428,041 | 901,926 | 513,294 | 500,018 | 1,013,312 | 1,915,239 | |
548,981 | 592,091 | 1,141,072 | 734,835 | 676,092 | 1,410,928 | 2,552,000 | 626,084 | 642,130 | 1,268,215 | 649,844 | 805,581 | 1,455,425 | 2,723,641 | |
Segment income | 494,096 | 399,653 | 893,750 | 347,684 | 228,720 | 576,405 | 1,470,155 | 562,485 | 281,396 | 843,881 | 156,437 | 286,227 | 442,664 | 1,286,546 |
Machinery Business Segment | 419,473 | 309,062 | 728,536 | 234,079 | 209,467 | 443,546 | 1,172,082 | 496,861 | 261,949 | 758,810 | 166,539 | 316,969 | 483,509 | 1,242,320 |
Chemicals Business Segment | 142,875 | 156,795 | 299,671 | 180,328 | 85,228 | 265,556 | 565,227 | 162,804 | 94,221 | 257,025 | 67,631 | 54,837 | 122,469 | 379,495 |
Adjustments | (68,252) | (66,204) | (134,456) | (66,722) | (65,974) | (132,697) | (267,154) | (97,180) | (74,774) | (171,955) | (77,733) | (85,580) | (163,313) | (335,268) |
Composition ratio (%) Machinery Business Segment Pharmaceutical Products Industrial Products Chemicals Business Segment Pharmaceutical Excipients Food Preservatives Dietary Supplement Products | 68.5% | 60.2% | 64.7% | 53.5% | 57.9% | 55.7% | 60.5% | 65.5% | 63.5% | 64.6% | 54.5% | 64.3% | 60.4% | 62.5% |
83.8% | 82.4% | 83.2% | 86.6% | 80.0% | 83.2% | 83.2% | 91.9% | 82.7% | 87.6% | 90.8% | 88.7% | 89.5% | 88.5% | |
16.2% | 17.6% | 16.8% | 13.4% | 20.0% | 16.8% | 16.8% | 8.1% | 17.3% | 12.4% | 9.2% | 11.3% | 10.5% | 11.5% | |
31.5% | 39.8% | 35.3% | 46.5% | 42.1% | 44.3% | 39.5% | 34.5% | 36.5% | 35.4% | 45.5% | 35.7% | 39.6% | 37.5% | |
30.3% | 34.8% | 32.6% | 31.7% | 29.2% | 30.5% | 31.5% | 31.6% | 30.5% | 31.1% | 27.8% | 29.5% | 28.7% | 29.8% | |
32.8% | 27.6% | 30.1% | 27.7% | 28.9% | 28.3% | 29.1% | 29.5% | 27.8% | 28.6% | 31.9% | 27.0% | 29.3% | 29.0% | |
36.9% | 37.6% | 37.3% | 40.6% | 42.0% | 41.3% | 39.4% | 38.9% | 41.7% | 40.3% | 40.3% | 43.5% | 42.0% | 41.2% | |
Segment income margin (%) Machinery Business Segment Chemicals Business Segment Year-over-year basis (%) Net sales Machinery Business Segment Chemicals Business Segment Segment income Machinery Business Segment Chemicals Business Segment | 12.9% | 13.0% | 13.0% | 11.3% | 9.4% | 10.3% | 11.8% | 16.3% | 9.8% | 13.2% | 8.6% | 9.5% | 9.2% | 11.3% |
9.6% | 10.0% | 9.8% | 10.0% | 5.3% | 7.8% | 8.7% | 10.1% | 6.1% | 8.2% | 4.2% | 3.0% | 3.5% | 5.7% | |
45.2% | 5.5% | 24.0% | 2.0% | -13.4% | -6.3% | 7.6% | -1.5% | 6.9% | 2.3% | -8.8% | 35.5% | 13.2% | 7.4% | |
55.4% | 1.2% | 26.7% | -10.4% | -21.6% | -16.5% | 3.5% | -5.9% | 13.0% | 2.1% | -7.0% | 50.4% | 22.7% | 11.0% | |
27.2% | 12.6% | 19.2% | 21.2% | 1.1% | 10.8% | 14.7% | 8.1% | -2.2% | 2.8% | -10.9% | 14.9% | 1.3% | 2.0% | |
270.0% | 34.8% | 107.8% | -10.4% | -7.5% | -9.2% | 38.0% | 13.8% | -29.6% | -5.6% | -55.0% | 25.1% | -23.2% | -12.5% | |
203.7% | 20.1% | 84.2% | -32.8% | 28.2% | -13.3% | 29.2% | 18.4% | -15.2% | 4.2% | -28.9% | 51.3% | 9.0% | 6.0% | |
88.7% | 40.6% | 60.0% | 56.3% | -49.2% | -6.2% | 20.2% | 13.9% | -39.9% | -14.2% | -62.5% | -35.7% | -53.9% | -32.9% |
By region
(¥thousand) | FY2/13 | FY2/14 | ||||||||||||
Q1 | Q2 | 1H | Q3 | Q4 | 2H | Full-Year | Q1 | Q2 | 1H | Q3 | Q4 | 2H | Full-Year | |
Net sales Japan Overseas North America South and Central America Europe Others | 4,728,509 3,455,720 1,272,788 288,344 305,470 253,952 425,021 | 3,950,865 2,989,558 961,306 309,973 298,887 235,869 116,576 | 8,679,375 6,445,279 2,234,095 598,318 604,357 489,821 541,597 | 3,886,900 3,393,616 493,283 81,566 94,795 215,134 101,787 | 3,830,664 2,961,864 868,800 268,207 111,418 67,842 421,331 | 7,717,564 6,355,480 1,362,084 349,774 206,214 282,976 523,119 | 16,396,939 12,800,760 3,596,179 948,092 810,571 772,797 1,064,717 | 4,656,831 3,991,311 665,519 275,741 15,103 309,931 64,743 | 4,224,845 3,294,830 930,015 538,056 33,085 239,033 119,840 | 8,881,677 7,286,142 1,595,535 813,797 48,188 548,965 184,583 | 3,545,402 2,704,615 840,787 99,851 444,780 106,817 189,338 | 5,189,203 3,243,197 1,946,005 589,983 886,980 45,698 423,342 | 8,734,606 5,947,813 2,786,793 689,835 1,331,760 152,515 612,681 | 17,616,284 13,233,955 4,382,328 1,503,632 1,379,949 701,481 797,264 |
Composition ratio (%) Japan Overseas North America South and Central America Europe Others | 73.1% 26.9% 6.1% 6.5% 5.4% 9.0% | 75.7% 24.3% 7.8% 7.6% 6.0% 3.0% | 74.3% 25.7% 6.9% 7.0% 5.6% 6.2% | 87.3% 12.7% 2.1% 2.4% 5.5% 2.6% | 77.3% 22.7% 7.0% 2.9% 1.8% 11.0% | 82.4% 17.6% 4.5% 2.7% 3.7% 6.8% | 78.1% 21.9% 5.8% 4.9% 4.7% 6.5% | 85.7% 14.3% 5.9% 0.3% 6.7% 1.4% | 78.0% 22.0% 12.7% 0.8% 5.7% 2.8% | 82.0% 18.0% 9.2% 0.5% 6.2% 2.1% | 76.3% 23.7% 2.8% 12.5% 3.0% 5.3% | 62.5% 37.5% 11.4% 17.1% 0.9% 8.2% | 68.1% 31.9% 7.9% 15.2% 1.7% 7.0% | 75.1% 24.9% 8.5% 7.8% 4.0% 4.5% |
Orders received and order backlog
(¥thousand) | FY2/13 | FY2/14 | ||||||||||||
Q1 | Q2 | 1H | Q3 | Q4 | 2H | Full-Year | Q1 | Q2 | 1H | Q3 | Q4 | 2H | Full-Year | |
Orders received Machinery Division Pharmaceutical Products Industrial Products Chemicals Division Order backlog (End of period) Machinery Division Pharmaceutical Products Industrial Products Chemicals Division | 3,359,785 2,699,558 2,261,214 438,343 660,227 5,709,701 5,260,683 4,708,880 551,802 449,018 | 2,696,549 1,998,284 1,794,146 204,137 698,265 5,493,291 4,938,098 4,497,376 440,722 555,192 | 6,056,335 4,697,842 4,055,361 642,481 1,358,492 5,493,291 4,938,098 4,497,376 440,722 555,192 | 2,811,569 2,002,841 1,626,066 376,774 808,728 5,471,233 4,883,770 4,369,016 514,753 587,463 | 3,249,813 2,572,309 2,226,229 346,080 677,503 5,809,647 5,263,125 4,740,313 522,811 546,522 | 6,061,382 4,575,150 3,852,295 722,854 1,486,232 5,809,647 5,263,125 4,740,313 522,811 546,522 | 12,117,717 9,272,992 7,907,656 1,365,335 2,844,725 5,809,647 5,263,125 4,740,313 522,811 546,522 | 3,524,560 3,026,676 2,682,948 343,728 497,883 5,925,573 5,440,014 4,798,107 641,907 485,559 | 3,255,872 2,491,904 2,280,170 211,733 763,968 5,868,875 5,328,716 4,909,920 418,796 540,158 | 6,780,432 5,518,580 4,963,118 555,461 1,261,852 5,868,875 5,328,716 4,909,920 418,796 540,158 | 3,349,700 2,696,100 2,565,630 130,470 653,599 6,688,794 6,144,881 5,739,624 405,256 543,913 | 2,674,419 1,852,633 1,697,615 155,017 821,786 5,551,931 4,991,812 4,775,007 216,804 560,118 | 6,024,120 4,548,734 4,263,246 285,488 1,475,386 5,551,931 4,991,812 4,775,007 216,804 560,118 | 12,804,553 10,067,314 9,226,364 840,950 2,737,238 5,551,931 4,991,812 4,775,007 216,804 560,118 |
Machinery orders received and order backlog
(¥thousand) | FY2/13 | FY2/14 | ||||||||||||
Q1 | Q2 | 1H | Q3 | Q4 | 2H | Full-Year | Q1 | Q2 | 1H | Q3 | Q4 | 2H | Full-Year | |
Machinery orders received | 2,699,558 | 1,998,284 | 4,697,842 | 2,002,841 | 2,572,309 | 4,575,150 | 9,272,992 | 3,026,676 | 2,491,904 | 5,518,580 | 2,696,100 | 1,852,633 | 4,548,734 | 10,067,314 |
Domestic | 1,991,811 | 1,435,146 | 3,426,958 | 1,259,188 | 1,445,541 | 2,704,730 | 6,131,688 | 1,797,413 | 1,547,629 | 3,345,043 | 1,453,089 | 1,172,385 | 2,625,474 | 5,970,518 |
Overseas | 707,746 | 563,137 | 1,270,883 | 743,652 | 1,126,767 | 1,870,420 | 3,141,303 | 1,229,263 | 944,274 | 2,173,537 | 1,243,011 | 680,248 | 1,923,259 | 4,096,796 |
FREUND-VECTOR orders received | 619,142 | 430,554 | 1,049,696 | 667,058 | 782,662 | 1,449,720 | 2,499,417 | 1,122,714 | 801,401 | 1,924,115 | 1,184,094 | 584,243 | 1,768,337 | 3,692,453 |
FREUND-VECTOR order backlog (End of period) | 1,001,240 | 783,817 | 783,817 | 1,058,593 | 1,107,930 | 1,107,930 | 1,107,930 | 1,920,880 | 2,014,644 | 2,014,644 | 2,446,270 | 1,492,956 | 1,492,956 | 1,492,956 |
Note: Orders received and order backlog of FREUND-VECTOR are after elimination of intra-company transactions.
Machinery sales
(¥thousand) | FY2/13 | FY2/14 | ||||||||||||
Q1 | Q2 | 1H | Q3 | Q4 | 2H | Full-Year | Q1 | Q2 | 1H | Q3 | Q4 | 2H | Full-Year | |
Machinery division Machinery sales FREUND CORPORATION FREUND-VECTOR FREUND-TURBO Operating income (befor elimination of intra-company transactions) FREUND-VECTOR FREUND-TURBO | 3,240,641 | 2,376,530 | 5,617,172 | 2,078,342 | 2,219,310 | 4,297,652 | 9,914,824 | 3,048,680 | 2,684,594 | 5,733,274 | 1,933,878 | 3,337,480 | 5,271,358 | 11,004,633 |
2,194,409 | 1,683,753 | 3,878,162 | 1,675,754 | 1,470,549 | 3,146,304 | 7,024,466 | 2,572,993 | 1,905,149 | 4,478,143 | 1,132,507 | 1,471,233 | 2,603,740 | 7,081,883 | |
1,034,988 | 695,768 | 1,730,757 | 395,306 | 857,723 | 1,253,029 | 2,983,787 | 499,034 | 763,865 | 1,262,899 | 781,597 | 1,848,258 | 2,629,855 | 3,892,755 | |
219,854 | 336,839 | 556,693 | 256,325 | 209,655 | 465,981 | 1,022,675 | 274,556 | 177,082 | 451,638 | 175,049 | 155,383 | 330,433 | 782,071 | |
81,932 | 38,063 | 119,996 | (62,049) | 89,478 | 27,429 | 147,425 | (18,430) | 30,493 | 12,063 | 35,008 | 122,909 | 157,917 | 169,980 | |
16,195 | 42,524 | 58,719 | 29,786 | (7,437) | 22,348 | 81,068 | 18,904 | (4,903) | 14,001 | (11,839) | 3,426 | (22,413) | (8,412) | |
By geographic region | 1,978,137 | 1,443,623 | 3,421,761 | 1,593,283 | 1,368,765 | 2,962,049 | 6,383,810 | 2,389,623 | 1,758,967 | 4,148,591 | 1,104,910 | 1,399,060 | 2,503,970 | 6,652,561 |
Japan | ||||||||||||||
North and South America | 593,815 | 608,861 | 1,202,676 | 176,362 | 379,625 | 555,988 | 1,758,664 | 290,844 | 571,141 | 861,986 | 544,631 | 1,476,964 | 2,021,595 | 2,883,582 |
Europe and Africa | 251,903 | 235,741 | 487,645 | 215,023 | 66,702 | 281,725 | 769,370 | 309,938 | 239,033 | 548,972 | 106,592 | 46,696 | 153,288 | 702,261 |
Middle East, Asia and Pacific | 416,784 | 88,304 | 505,089 | 93,673 | 404,216 | 497,889 | 1,002,978 | 58,272 | 115,451 | 173,724 | 177,743 | 414,758 | 592,502 | 766,227 |
Composition ratio (%) Machinery sales FREUND CORPORATION FREUND-VECTOR FREUND-TURBO By geographic region Japan North and South America Europe and Africa Middle East, Asia and Pacific | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
67.7% | 70.8% | 69.0% | 80.6% | 66.3% | 73.2% | 70.8% | 84.4% | 71.0% | 78.1% | 58.6% | 44.1% | 49.4% | 64.4% | |
31.9% | 29.3% | 30.8% | 19.0% | 38.6% | 29.2% | 30.1% | 16.4% | 28.5% | 22.0% | 40.4% | 55.4% | 49.9% | 35.4% | |
6.8% | 14.2% | 9.9% | 12.3% | 9.4% | 10.8% | 10.3% | 9.0% | 6.6% | 7.9% | 9.1% | 4.7% | 6.3% | 7.1% | |
61.0% | 60.7% | 60.9% | 76.7% | 61.7% | 68.9% | 64.4% | 78.4% | 65.5% | 72.4% | 57.1% | 41.9% | 47.5% | 60.5% | |
18.3% | 25.6% | 21.4% | 8.5% | 17.1% | 12.9% | 17.7% | 9.5% | 21.3% | 15.0% | 28.2% | 44.3% | 38.4% | 26.2% | |
7.8% | 9.9% | 8.7% | 10.3% | 3.0% | 6.6% | 7.8% | 10.2% | 8.9% | 9.6% | 5.5% | 1.4% | 2.9% | 6.4% | |
12.9% | 3.7% | 9.0% | 4.5% | 18.2% | 11.6% | 10.1% | 1.9% | 4.3% | 3.0% | 9.2% | 12.4% | 11.2% | 7.0% | |
Operating income margin | 7.9% | 5.5% | 6.9% | -15.7% | 10.4% | 2.2% | 4.9% | -3.7% | 4.0% | 1.0% | 4.5% | 6.7% | 6.0% | 4.4% |
FREUND-VECTOR | ||||||||||||||
FREUND-TURBO | 7.4% | 12.6% | 10.5% | 11.6% | -3.5% | 4.8% | 7.9% | 6.9% | -2.8% | 3.1% | -6.8% | 2.2% | -6.8% | -1.1% |
PL
(¥thousand) | FY2/15 | FY2/16 | ||||||||||||
Q1 | Q2 | 1H | Q3 | Q4 | 2H | Full-Year | Q1 | Q2 | 1H | Q3 | Q4 | 2H | Full-Year | |
Net sales Cost of sales Gross profit Selling, general and administrative expenses Operating income Non-operating income Foreign exchange gains Non-operating expenses Ordinary income Extraordinary income Extraordinary losses Income (loss) before income taxes and minority interests Total income taxes Profit (loss) attributable to non-controlling interests Profit (loss) attributable to owners of parent EBITDA EBITDA=Operating income+Technical support fee+Interest expenses+Depreciation | 3,506,699 2,454,079 1,052,620 1,073,496 (20,876) 24,398 - 4,247 (725) - 860 (1,586) 30,662 (2,290) (29,959) 62,750 | 3,865,222 2,747,253 1,117,969 996,013 121,955 20,544 4,709 692 141,807 2,360 1,761 142,405 74,057 2,284 66,063 200,447 | 7,371,922 5,201,333 2,170,589 2,069,510 101,078 44,942 4,709 4,939 141,081 2,360 2,622 140,819 104,720 (5) 36,104 263,197 | 4,639,168 3,065,072 1,574,096 1,090,104 483,991 43,688 34,181 1,462 526,217 3,355 2,329 527,243 216,883 9,809 300,551 567,004 | 5,413,187 3,711,992 1,701,195 1,135,923 565,271 18,065 5,948 1,094 582,243 4,314 1,555 585,002 215,164 10,527 359,310 648,374 | 10,052,356 6,777,064 3,275,291 2,226,028 1,049,263 61,754 40,129 2,556 1,108,460 7,669 3,884 1,112,246 432,047 20,336 659,861 1,215,378 | 17,424,279 11,978,398 5,445,881 4,295,538 1,150,342 106,696 44,839 7,496 1,249,542 10,030 6,507 1,253,065 536,768 20,330 695,966 1,478,575 | 3,002,638 1,976,563 1,026,074 1,050,574 (24,500) 25,052 12,837 1,020 (468) - 3,236 (3,704) 28,549 (3,134) (29,120) 58,508 | 4,694,781 3,289,855 1,404,925 1,181,533 223,392 30,341 (7,355) 1,036 252,697 859 0 253,557 104,401 (3,603) 152,760 315,993 | 7,697,419 5,266,419 2,431,000 2,232,108 198,892 55,394 5,482 2,056 252,229 859 3,236 249,853 132,951 (6,738) 123,639 374,501 | 5,384,281 3,665,030 1,719,250 1,190,983 528,267 5,003 131 1,075 532,195 45 22,338 509,901 211,235 (38) 298,704 451,985 | 5,945,932 3,990,069 1,955,863 1,336,081 619,781 4,480 (5,614) 14,033 610,228 2,925 231,270 381,883 (156,894) (6) 538,784 860,905 | 11,330,214 7,655,099 3,675,114 2,527,065 1,148,049 9,483 (5,482) 15,108 1,142,424 2,970 253,609 891,784 54,340 (45) 837,489 1,312,890 | 19,027,633 12,921,519 6,106,114 4,759,173 1,346,941 64,877 0 17,165 1,394,653 3,830 256,845 1,141,638 187,292 (6,783) 961,129 1,687,391 |
Foreign exchange rate (Average exchange rate of cumulative period) /US$ | 102.77 | 102.46 | 102.46 | 102.93 | 105.79 | 105.79 | 105.79 | 119.16 | 120.30 | 120.30 | 120.98 | 121.10 | 121.10 | 121.10 |
Capital investment (including acquisition of leased assets) Depreciation R&D expenses | 62,079 79,070 139,855 | 81,743 74,672 159,967 | 143,823 153,743 299,823 | 170,470 76,646 147,230 | 231,487 77,981 145,559 | 401,957 154,627 292,789 | 545,780 308,370 592,613 | 56,601 79,876 137,669 | 27,012 83,882 137,497 | 83,613 163,759 275,166 | 108,847 84,130 176,929 | 73,861 74,008 235,162 | 182,708 158,138 412,091 | 266,322 321,898 687,257 |
Composition ratio (%) COGS ratio Gross profit margin SG&A expenses ratio Operating income margin Ordinary income margin Net income margin R&D expenses ratio | 70.0% 30.0% 30.6% -0.6% 0.0% -0.9% 4.0% | 71.1% 28.9% 25.8% 3.2% 3.7% 1.7% 4.1% | 70.6% 29.4% 28.1% 1.4% 1.9% 0.5% 4.1% | 66.1% 33.9% 23.5% 10.4% 11.3% 6.5% 3.2% | 68.6% 31.4% 21.0% 10.4% 10.8% 6.6% 2.7% | 67.4% 32.6% 22.1% 10.4% 11.0% 6.6% 2.9% | 68.7% 31.3% 24.7% 6.6% 7.2% 4.0% 3.4% | 65.8% 34.2% 35.0% -0.8% 0.0% -1.0% 4.6% | 70.1% 29.9% 25.2% 4.8% 5.4% 3.3% 2.9% | 68.4% 31.6% 29.0% 2.6% 3.3% 1.6% 3.6% | 68.1% 31.9% 22.1% 9.8% 9.9% 5.5% 3.3% | 67.1% 32.9% 22.5% 10.4% 10.3% 9.1% 4.0% | 67.6% 32.4% 22.3% 10.1% 10.1% 7.4% 3.6% | 67.9% 32.1% 25.0% 7.1% 7.3% 5.1% 3.6% |
Year-over-year basis (%) Net sales Cost of sales Gross profit Selling, general and administrative expenses Operating income | -24.7% -21.0% -32.1% 8.7% - | -8.5% -7.3% -11.4% 1.6% -56.7% | -17.0% -14.3% -22.8% 5.2% -88.0% | 30.9% 24.2% 46.2% 18.5% 209.4% | 4.3% -3.3% 25.9% 6.7% 97.5% | 15.1% 7.5% 34.9% 12.2% 137.0% | -1.1% -3.2% 4.0% 8.7% -10.6% | -14.4% -19.5% -2.5% -2.1% - | 21.5% 19.8% 25.7% 18.6% 83.2% | 4.4% 1.3% 12.0% 7.9% 96.8% | 16.1% 19.6% 9.2% 9.3% 9.1% | 9.8% 7.5% 15.0% 17.6% 9.6% | 12.7% 13.0% 12.2% 13.5% 9.4% | 9.2% 7.9% 12.1% 10.8% 17.1% |
Freund Corporation published this content on 11 January 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 11 January 2017 07:58:04 UTC.
Original documenthttp://www.freund.co.jp/english/docs/doc_FACT_q3fy201702_eng.pdf
Public permalinkhttp://www.publicnow.com/view/690BAC9C4F014975D394ED7A359927CDF647A6DA